|

Standard of Care Treatment Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Pipeline

Phase 3: 1Phase 2/3: 1

Top Sponsors

  • Kyverna Therapeutics1
  • Janssen Research & Development, LLC1

Indications

  • Lupus Erythematosus, Systemic1
  • Lupus1
  • Myasthenia Gravis1
  • Generalized Myasthenia Gravis1
  • Cancer1

Beverly Hills, California1 trial

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

David S Hallegua MD A Professional Corporation

Phase 3

Orange, California1 trial

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

University of California, Irvine

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.